Helse Fonna HF

Haugesund 12 trials 8 recruiting

12 Registered trials

8 Currently recruiting

Organisation

Helse Fonna HF

Location

Haugesund, Norway

Identifier

ORG-100040422

Address

P. O. Box 2170, 5504, Norway

Departments

Age Related Medicine
Department of Medicine
Department of Neurology
department of pulmonary disease
Dpt of oncology
Medisinsk avdeling
Old age psychiatry
Oncology
Pediatric department
Pulmanory Medicine Department

Clinical trials at this site (12)

Search interface

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Diabetes Mellitus, Type 1 5 2026-02-03
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Immune Thrombocytopenia (ITP) 5 2025-07-01
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Cancer 4 2025-03-27
A Placebo-Controlled, Randomized Double-Blind Parallel Group 12-Month Trial of Fasudil for the Treatment of Early Alzheimer’s Disease Recruiting

2023-506514-44-00 Alzheimer's disease 4 2024-06-11
The CORTAD study Recruiting

2024-512888-31-00 Primary adrenal insufficiency (PAI) 11 2023-08-03
Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities (SOLUCOM) Recruiting

2023-503174-20-00 KRAS G12C-mutated non-small cell lung cancer 4 2022-05-30
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01
A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric an… Recruiting

2024-510720-38-00 Dementia with Lewy Bodies 4 2021-01-12
PErsonalized TREatment of high-risk MAmmary Cancer - the PETREMAC trial Ended

2024-519364-40-00 Breast cancer 4 2024-11-29
Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with exten… Ended

2023-505514-15-00 Small-cell lung cancer, extensive stage 5 2022-01-11
A PHASE 1B DOSE RANGE FINDING STUDY OF PHENSERINE COMPARED TO DONEPEZIL IN PARTICIPANTS WITH EARLY OR MILD ALZHEIMER’S DISEASE Ended

2023-510282-10-00 Mild Cognitive Impairment 3 2025-02-11
The TAF-MS study Ended

2023-503814-62-00 Multiple sclerosis 4 2024-02-06